Independent research at the University of St Andrews, led by Dr. Catherine Adamson, of the School of Biology, who specializes in Viral diseasesThe superior effectiveness of Alphasite during laboratory testing against coronaviruses.
Dr. Adamson, who supervised the tests, said: “This is a very exciting development, and it appears that there is a big difference in the vital activity of subtypes of interferons against corona viruses. These differences may have important therapeutic effects for Covid-19.”
The Alphasite Therapy was invented by Professor William Stimson, Founder and Senior Scientific Director, the ILC Therapy Biotechnology Foundation.
Dr. Alan Walker, CEO of the company, welcomed the results as an important development in Combating Covid-19“This is a very positive development, as the world is preparing to face the second wave. Curative interventions are necessary for us to tame the disease,” he said.
He added, “The innate immune system acts as an immune wall against Viral infection. If we can stop the virus at certain limits, and this wall enables the adaptive immune response to be prepared for battle, and Covid-19 will not be able to progress. “
Alpha-interferons are a family of 12 natural proteins. So far, only one therapeutic subtype is used, interferon alpha2.
It is also worth noting that the original news has been published and is available at eg24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.